Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA3246905
Max Phase: Preclinical
Molecular Formula: C20H22O2
Molecular Weight: 294.39
Molecule Type: Small molecule
Associated Items:
ID: ALA3246905
Max Phase: Preclinical
Molecular Formula: C20H22O2
Molecular Weight: 294.39
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: CC(CCc1ccc2c(c1)-c1ccccc1CC2)CC(=O)O
Standard InChI: InChI=1S/C20H22O2/c1-14(12-20(21)22)6-7-15-8-9-17-11-10-16-4-2-3-5-18(16)19(17)13-15/h2-5,8-9,13-14H,6-7,10-12H2,1H3,(H,21,22)
Standard InChI Key: LWHYQVFAHZASJH-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 294.39 | Molecular Weight (Monoisotopic): 294.1620 | AlogP: 4.50 | #Rotatable Bonds: 5 |
Polar Surface Area: 37.30 | Molecular Species: ACID | HBA: 1 | HBD: 1 |
#RO5 Violations: 0 | HBA (Lipinski): 2 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: 4.75 | CX Basic pKa: | CX LogP: 5.44 | CX LogD: 2.84 |
Aromatic Rings: 2 | Heavy Atoms: 22 | QED Weighted: 0.88 | Np Likeness Score: 0.47 |
1. Dygos JH, Jett CM, Chinn LJ, Miller JE.. (1977) Hypolipidemic activity of 5-aryl-3-methylvaleric acid derivatives., 20 (12): [PMID:592342] [10.1021/jm00222a039] |
Source(1):